Holen Sie sich die Stockscreener-App
238.30
0.18%
-1.26
Schlusskurs vom Vortag:
$239.56
Offen:
$241.84
24-Stunden-Volumen:
108.23K
Relative Volume:
0.08
Marktkapitalisierung:
$33.28B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-104.33
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
+4.50%
1M Leistung:
+1.53%
6M Leistung:
+47.85%
1J Leistung:
+35.41%
1-Tages-Spanne:
$237.73
$241.90
1-Wochen-Bereich:
$227.69
$256.36
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
238.66 | 33.41B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
612.51 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.66 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
710.57 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.68 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
245.55 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Will Natera Inc. stock outperform tech sector in 2025Insider Buying & Real-Time Stock Entry Alerts - ulpravda.ru
Can Natera Inc. stock sustain market leadership2025 AllTime Highs & Risk Controlled Stock Pick Alerts - ulpravda.ru
Is Natera Inc. stock attractive for growth ETFs2025 Top Gainers & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Will Natera Inc. stock gain from strong economyQuarterly Portfolio Report & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Can Natera Inc. stock weather global recessionJuly 2025 Momentum & Reliable Entry Point Alerts - ulpravda.ru
Can Natera Inc. stock beat analyst upgradesJuly 2025 Opening Moves & Real-Time Chart Pattern Alerts - ulpravda.ru
EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study - Finviz
Assessing Natera (NTRA) Valuation After Positive ALTAIR Trial Data And Expanded Fetal Focus Test Launch - simplywall.st
Medical stock hovers near buy point after 46% gain - MSN
Why Natera’s Stock Is Sliding Despite Bullish Outlook - TipRanks
Natera (NTRA) announces publication of findings from randomized, phase III CALGB (Alliance)/SWOG 80702 study - MSN
Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera - CNBC
Exelixis and Natera stocks rise on colorectal cancer trial collaboration By Investing.com - Investing.com South Africa
Exelixis and Natera stocks rise on colorectal cancer trial collaboration - Investing.com
Exelixis, Natera to Collaborate on Phase 3 Colorectal Cancer Trial - MarketScreener
Exelixis and Natera to collaborate on Stellar-316, a phase 3 pivotal trial of zanzalintinib - MarketScreener
Insiders At Natera Sold US$47m In Stock, Alluding To Potential Weakness - Yahoo Finance
Citigroup Initiates Buy Rating on Natera (NTRA) with $300 Price Target | NTRA Stock News - GuruFocus
Exelixis and Natera to collaborate on MRD-guided cancer trial By Investing.com - Investing.com Australia
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer - Yahoo Finance
Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target - TipRanks
Natera Inc: President Moshkevich sells $675k in stock By Investing.com - Investing.com South Africa
Natera Inc: President Moshkevich sells $675k in stock - Investing.com India
Natera Inc stock hits all-time high at 247.0 USD - Investing.com
Expanded Fetal Test and Stronger ALTAIR Signal Could Be A Game Changer For Natera (NTRA) - simplywall.st
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI - The AI Journal
NTRA Gains Momentum as Guggenheim Raises Price Target to $270 | - GuruFocus
New prenatal blood test flags 21 inherited diseases with high accuracy - Stock Titan
Is Natera (NASDAQ:NTRA) A Risky Investment? - 富途牛牛
Natera (NASDAQ:NTRA) Upgraded at Zacks Research - MarketBeat
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Calamos Advisors LLC Has $930,000 Holdings in Natera, Inc. $NTRA - MarketBeat
Responsive Playbooks and the NTRA Inflection - Stock Traders Daily
Ninety One UK Ltd Sells 218,812 Shares of Natera, Inc. $NTRA - MarketBeat
Allspring Global Investments Holdings LLC Sells 47,131 Shares of Natera, Inc. $NTRA - MarketBeat
Miami man arrested in nearly $1 million theft from tech company he worked for: Cops - NBC 6 South Florida
Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study - Finviz
Miami man accused of stealing nearly $1 million from 2 South Florida businesses - WPLG Local 10
Natera, Inc. (NASDAQ:NTRA) Short Interest Update - MarketBeat
Natera CFO sells shares worth $7.76 million - MSN
Medical Stock Hovers Near Buy Point After 46% Gain - Investor's Business Daily
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail
Cwm LLC Increases Stake in Natera, Inc. $NTRA - MarketBeat
Vontobel Holding Ltd. Increases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera is Transforming Patient Care Using AI - Amazon Web Services (AWS)
Natera: Is Signatera’s Momentum About to Accelerate Again as Biomarker Laws Expand State by State? - Smartkarma
Natera, Inc. $NTRA Shares Bought by SWS Partners - MarketBeat
Is Natera’s 486% Three Year Surge Still Justified by Its Fundamentals? - Yahoo Finance
3 Reasons We’re Fans of Natera (NTRA) - Barchart.com
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Jan 02 '26 |
Sale |
228.95 |
2,951 |
675,621 |
123,499 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Jan 02 '26 |
Sale |
229.08 |
3,848 |
881,482 |
136,568 |
0.77%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):